FDA NDC Directory · JSON-LD · Markdown
NDC 62541-404 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE
| Generic name | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE |
|---|---|
| Labeler / Manufacturer | VIVUS LLC |
| Marketing category | Biologic License Application · App BLA022523 |
| Dosage form / route | CAPSULE, DELAYED RELEASE · ORAL |
| Active ingredients | PANCRELIPASE AMYLASE (98400 [USP'U]/1) PANCRELIPASE LIPASE (16800 [USP'U]/1) PANCRELIPASE PROTEASE (56800 [USP'U]/1) |
| Marketing started | 20100412 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).